In contrast, Li et al. demonstrated that ARID1A aberrations led to impaired chromatin accessibility to IFN-responsive genes, limited IFN gene expression, poor tumor immunity and attenuated host survival in both experimental models and patient samples [67]. This evidence concerns the gene IFNA1 and neoplasm.